Centralised authorisation procedure 2024

05 May 2025

The Danish share of assignments in the European pharmaceutical collaboration

The Danish Medicines Agency should have the greatest possible influence on decisions regarding new medicinal products and thereby the greatest possible influence on the future development of the European market for medicinal products.

Status for 2024 up to and including 4th quarter: Denmark was assigned 14 human rapporteur/co-rapporteur cases and 6 veterinary rapporteur/co-rapporteur cases, which is respectively 6 % and 9 % of all assigned central procedure cases in 2024.

Figure 1: Amount of assigned (co)rapporteurships in the EU in 2024 up to and including 4th quarter

Figure 2. Share of human Rap/Co-rap cases

Table 1: Assigned human Rapporteur/co-rapporteur cases

Number of human procedures

2023

2024

Cases with DK as Rap/Co-rap

Total amount of cases

Cases with DK as Rap/Co-rap

Total amount of cases

1st quarter

4

53

6

75

2nd quarter

5

49

4

50

3rd quarter

4

50

2

56

4th quarter

3

70

2

54

Total

16

222

14

235

 

Figure 3. Share of veterinary Rap/Co-rap cases

Table 2: Assigned veterinary Rapporteur cases/co-rapporteur cases

Number of veterinary procedures

2023

2024

Cases with DK as Rap/Co-rap

Total amount of cases

Cases with DK as Rap/Co-rap

Total amount of cases

1st quarter

0

12

3

16

2nd quarter

1

16

0

10

3rd quarter

0

10

2

20

4th quarter

2

16

1

22

Total

3

54

6

68

 

Please contact Send an email for further information.